Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 1.00 |
| ▸ | TYR | P14679 | 3/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 3/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA1 | P00915 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | CA9 | Q16790 | 3/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 3/20 | 1.00 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | CA3 | P07451 | 2/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | CA6 | P23280 | 2/20 | 1.00 |
| ▸ | DPP4 | P27487 | 2/20 | 1.00 |
| ▸ | CA5A | P35218 | 2/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 1.00 |
| ▸ | F3 | P13726 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coumaric Acid SCHEMBL6333102 | 1.00 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL39106 | 1.00 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL6333097 | 1.00 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL20702657 | 1.00 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL43601 | 1.00 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL6328280 | 0.98 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL1221500 | 0.98 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL7871865 | 0.98 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL7040450 | 0.98 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL5606477 | 0.98 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024033288-A1 | SALICIN DERIVATIVES AS INHIBITORS OF SGLT2 | Société des Produits Nestlé S.A. (CH) | 2024-02-15 | — | — | WO | claimed |
| CN-111562340-B | Method for rapidly carrying out species analysis and content determination on anthocyanin in tomato fruits | 中国农业科学院蔬菜花卉研究所 | 2023-02-07 | — | — | CN | claimed |
| CN-107753542-B | South American wedelia chinensis antioxidant extract and preparation method and application thereof | 海南师范大学 | 2021-05-07 | — | — | CN | claimed |
| US-20110183929-A1 | STANDARDIZED EXTRACT AND FRACTION FROM HANCORNIA SPECIOSA LEAVES AND PHARMACEUTICAL COMPOSITION THEREOF | UNIVERSIDADE FEDERAL DE MINAS GERAIS (BR) | 2011-07-28 | — | — | US | claimed |
| EP-2335711-A2 | EXTRACT OF HANCORNIA SPECIOSA AND PHARMACEUTICAL COMPOSITION THEREOF | Universidade Federal de Minas Gerais-UFMG (BR) | 2011-06-22 | — | — | EP | claimed |
| CN-1247606-C | Two (2)-4-hydroxycinnamic acid glycosides and their application | RES INST OF OCEAN OF THE SOUTH (CN) | 2006-03-29 | — | — | CN | claimed |
| CN-1515580-A | Two (2)-4-hydroxycinnamic acid glycosides and their application | 中国科学院南海海洋研究所 | 2004-07-28 | — | — | CN | claimed |
| US-20260101892-A1 | METHOD TO INHIBIT PROLIFERATION OF A PHYTOPATHOGEN ON PLANTS AND COMPOSITIONS USED FOR THIS PURPOSE | CYSBIO APS (DK) | 2026-04-16 | — | — | US | disclosed |
| US-20260076954-A1 | COMPOSITIONS AND METHODS FOR REDUCING CANCER STEM CELLS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2026-03-19 | — | — | US | disclosed |
| US-12544368-B2 | Compositions and methods for reducing cancer stem cells | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250351855-A1 | TASTE OF CONSUMABLES | THE PRODUCT MAKERS (AUSTRALIA) PTY LTD (AU) | 2025-11-20 | — | — | US | disclosed |
| US-12370232-B2 | Use of polyphenol containing sugar cane extracts for preventing, improving or treating a skin condition | Poly Gain Pte Ltd (SG) | 2025-07-29 | — | — | US | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| US-4681954-A | 7,8,9,10-tetrahydro-6-oxo-6H-dibenzo(b,d)pyranyloxy-propanes | PENNWALT CORPORATION (US) | 1987-07-21 | — | — | US | disclosed |
| EP-0221293-A1 | 7,8,9,10-Tetrahydro-6-oxo-6H-dibenzo[b,d]pyranyloxy-propanes | PENNWALT CORPORATION (US) | 1987-05-13 | — | — | EP | disclosed |
| EP-0039472-B1 | RADIATION-CROSSLINKABLE POLYESTERS AND POLYESTERETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-08-15 | — | — | EP | disclosed |
| US-4343888-A | Use of radiation crosslinkable polyesters and polyesterethers in printing plates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-08-10 | — | — | US | disclosed |
| EP-0039472-A1 | Radiation-crosslinkable polyesters and polyesterethers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-11-11 | — | — | EP | disclosed |
| US-4284710-A | FROM DIEPOXIDE AND AROMATIC UNSATURATED DICARBOXYLIC ACID OR HYDROXY ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-08-18 | — | — | US | disclosed |
| US-4247597-A | Electroscopic carrier particles having a carboxylic acid surface treatment | PITNEY BOWES, INC. (US) | 1981-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260101892-A1 | METHOD TO INHIBIT PROLIFERATION OF A PHYTOPATHOGEN ON PLANTS AND COMPOSITIONS USED FOR THIS PURPOSE | HAAO, NOTUM, WEE1 | ESR1 4318/4885TYR 23/4885AKR1B10 3264/4885 |
| US-12544368-B2 | Compositions and methods for reducing cancer stem cells | MCL1, BCL9, MYADM | ESR1 1189/4885TYR 4081/4885AKR1B10 1621/4885 |
| US-20260076954-A1 | COMPOSITIONS AND METHODS FOR REDUCING CANCER STEM CELLS | MCL1, FLT3, MYADM | ESR1 666/4885TYR 3984/4885AKR1B10 2498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.